122 related articles for article (PubMed ID: 22882535)
41. Differential regulation of rat testicular 5alpha-reductase type 1 and 2 isoforms by testosterone and FSH.
Pratis K; O'Donnell L; Ooi GT; Stanton PG; McLachlan RI; Robertson DM
J Endocrinol; 2003 Mar; 176(3):393-403. PubMed ID: 12630924
[TBL] [Abstract][Full Text] [Related]
42. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias.
Wang R; Dong Z; Wang W; Xiao Y; Ni J; Wang D
J Pediatr Endocrinol Metab; 2013; 26(9-10):887-93. PubMed ID: 23729601
[TBL] [Abstract][Full Text] [Related]
43. Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene.
Fernández-Cancio M; Rodó J; Andaluz P; Martínez de Osaba MJ; Rodríguez-Hierro F; Esteban C; Carrascosa A; Audí L
Horm Res; 2004; 62(5):259-64. PubMed ID: 15528927
[TBL] [Abstract][Full Text] [Related]
44. Transcripts of genes encoding reproductive neuroendocrine hormones and androgen receptor in the brain and testis of goldfish exposed to vinclozolin, flutamide, testosterone, and their combinations.
Golshan M; Habibi HR; Alavi SM
Fish Physiol Biochem; 2016 Aug; 42(4):1157-65. PubMed ID: 26899179
[TBL] [Abstract][Full Text] [Related]
45. SRD5A2 gene polymorphisms affect the risk of breast cancer.
Francis A; Sarkar S; Pooja S; Surekha D; Rao DR; Rao L; Ramachandra L; Vishnupriya S; Satyamoorthy K; Thangaraj K; Rajender S
Breast; 2014 Apr; 23(2):137-41. PubMed ID: 24365257
[TBL] [Abstract][Full Text] [Related]
46. Association of a tagging single nucleotide polymorphism in the androgen receptor gene region with susceptibility to severe hypospadias in a Caucasian population.
Adamovic T; Thai HT; Liedén A; Nordenskjöld A
Sex Dev; 2013; 7(4):173-9. PubMed ID: 23571770
[TBL] [Abstract][Full Text] [Related]
47. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
[TBL] [Abstract][Full Text] [Related]
48. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
[TBL] [Abstract][Full Text] [Related]
49. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
Choi SY; Kim HJ; Cheong HS; Myung SC
Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
[TBL] [Abstract][Full Text] [Related]
50. Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population.
Heimdal K; Andersen TI; Skrede M; Fosså SD; Berg K; Børresen AL
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):123-6. PubMed ID: 7742719
[TBL] [Abstract][Full Text] [Related]
51. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
[TBL] [Abstract][Full Text] [Related]
52. Molecular analysis of the androgen receptor gene in testicular cancer.
Garolla A; Ferlin A; Vinanzi C; Roverato A; Sotti G; Artibani W; Foresta C
Endocr Relat Cancer; 2005 Sep; 12(3):645-55. PubMed ID: 16172197
[TBL] [Abstract][Full Text] [Related]
53. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor.
Martin MM; Wu SM; Martin AL; Rennert OM; Chan WY
Eur J Endocrinol; 1998 Jul; 139(1):101-6. PubMed ID: 9703386
[TBL] [Abstract][Full Text] [Related]
54. Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men.
Huhtaniemi IT; Pye SR; Holliday KL; Thomson W; O'Neill TW; Platt H; Payne D; John SL; Jiang M; Bartfai G; Boonen S; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Vanderschueren D; Labrie F; Wu FC;
J Clin Endocrinol Metab; 2010 Apr; 95(4):1898-908. PubMed ID: 20173016
[TBL] [Abstract][Full Text] [Related]
55. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.
Onen IH; Ekmekci A; Eroglu M; Polat F; Biri H
DNA Cell Biol; 2007 Feb; 26(2):100-7. PubMed ID: 17328668
[TBL] [Abstract][Full Text] [Related]
56. Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.
Audet-Walsh É; Yee T; Tam IS; Giguère V
Endocrinology; 2017 Apr; 158(4):1015-1021. PubMed ID: 28324044
[TBL] [Abstract][Full Text] [Related]
57. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
[TBL] [Abstract][Full Text] [Related]
58. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
Wang Z; Hu L; Salari K; Bechis SK; Ge R; Wu S; Rassoulian C; Pham J; Wu CL; Tabatabaei S; Strand DW; Olumi AF
J Pathol; 2017 Dec; 243(4):457-467. PubMed ID: 28940538
[TBL] [Abstract][Full Text] [Related]
59. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
60. Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.
Yamada Y; Watanabe M; Murata M; Yamanaka M; Kubota Y; Ito H; Katoh T; Kawamura J; Yatani R; Shiraishi T
Int J Cancer; 2001 Jun; 92(5):683-6. PubMed ID: 11340572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
